December 15 (SeeNews) - The Bulgarian government said it decided to increase the capital of state-owned vaccine manufacturer Bul Bio by 7.56 million levs ($4.1 million/3.87 million euro) to fund the construction of a refrigeration facility for storing human blood plasma.
The capital increase will be carried out by registering new shares with a face value of 10 levs each, the government said in a statement on Wednesday.
The planned facility will store human plasma which is used for the manufacturing of human blood products such as Bul Bio’s Immunovenin-intact 5 and Albumin 20 % BB solution for infusion.
Sofia-based Bul Bio is wholly-owned by the health ministry. The company produces more than 600 medicines, divided into two main groups - human medicines and in-vitro diagnostic medicine products, according to information published on its website.
(1 euro = 1.95583 levs)